- Home
- GITS vs ACON Comparison
GITS vs ACON Comparison
Compare GITS & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GITS | ACON |
|---|---|---|
| Founded | 2018 | 2008 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | | Retail: Computer Software & Peripheral Equipment |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8M | 3.0M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | GITS | ACON |
|---|---|---|
| Price | $2.75 | $2.75 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $23.00 |
| AVG Volume (30 Days) | ★ 7.7M | 195.0K |
| Earning Date | 11-12-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,867.00 | ★ $67,483.00 |
| Revenue This Year | N/A | $71.77 |
| Revenue Next Year | N/A | $80.52 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 36.91 |
| 52 Week Low | $0.66 | $2.34 |
| 52 Week High | $7.09 | $229.50 |
Technical Indicators
Market Signals| Indicator | GITS | ACON |
|---|---|---|
| Relative Strength Index (RSI) | 53.33 | 34.10 |
| Support Level | $2.62 | $2.34 |
| Resistance Level | $4.65 | $2.85 |
| Average True Range (ATR) | 1.09 | 0.25 |
| MACD | -0.10 | 0.01 |
| Stochastic Oscillator | 16.16 | 24.35 |
Price Performance
Historical ComparisonAbout GITS Global Interactive Technologies Inc.
Global Interactive Technologies Inc, formerly Hanryu Holdings Inc is the creator of the engaging social media platform, FANTOO. Through FANTOO, it provides a multi-media platform for its users to interact with other like-minded users, share their appreciation of various types of entertainment and cultures, create their content, enjoy content, and engage in commerce.
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.